Join our new priority response service
Designing a successful allergen cleaning validation study
Diversity & Inclusion
Insights & resources
The rapid rise in the number of biopharmaceuticals has altered the face of the global pharmaceutical marketplace, and this will continue as patents expire, opening the way for biosimilar competition.
Whether they are innovator molecules or biosimilars, biotechnological and biological products that are derived from cell culture require a set of formalised specifications in accordance with ICH Q6B, FDA and EMEA guidelines. These guidelines outline the path to fully understanding the structural, physiochemical, immunological and biological properties of the product. RSSL can support you by providing the services, capabilities and expertise you need to meet these guidelines.
With over 30 years of experience in the pharmaceutical industry, our multidisciplinary team and extensive portfolio of biological, microbiological, chemical and physical services, we will help you to ensure the identity, purity, safety and quality of your biologic.
Switchboard: +44 (0)118 918 4000
+44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.